SOS
ARKG icon

Silver Oak Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Silver Oak Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,046
Closed -$222K – 445
2022
Q2 		$222K Sell
6,046
-1,212
-17% -$42.4K 0.05% 241
2022
Q1 		$317K Buy
+7,258
New +$346K 0.06% 227

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Silver Oak Securities's ARKG Position: Q3 2022 in Review

Silver Oak Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 6,046 shares — an estimated $222K sold.

Silver Oak Securities first reported a position in ARKG in Q1 2022 and held it in 2 quarters. The position peaked at $317K in Q1 2022. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • Silver Oak Securities reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • Silver Oak Securities sold 6,046 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $222K.
  • Silver Oak Securities first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 2 quarters.
  • Silver Oak Securities's ARK Genomic Revolution ETF position peaked at $317K in Q1 2022.
  • 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Silver Oak Securities's 13F filing for Q3 2022, filed 20 Oct 2022.